September 30, 2004

Mr. Richard Gabriel
President & CEO
DNAPrint genomics, Inc.
900 Cocoanut Avenue
Sarasota, FL 34236

Dear Mr. Gabriel:

      This will  confirm  our  understanding  that The Wall Street  Group,  Inc.
("WSG") has been  retained as  financial  public  relations  counsel to DNAPrint
genomics,  Inc. ("DNAPrint"),  beginning September 30, 2004 and continuing until
cancelled as hereinafter provided. As consideration for the services provided by
WSG to DNAPrint, as defined more specifically on Exhibit "A" attached,  WSG will
receive a cash fee of $7,500 per  month,  payable in advance on the first day of
each  month,  plus  reimbursement  of  reasonable  and  customary  out-of-pocket
expenses,  payable on receipt of an itemized  statement  detailing  the incurred
expenses. As further consideration, DNAPrint grants WSG's affiliate, Wall Street
Consultant's, Inc. ("WSC") a five-year stock option, with piggyback registration
rights as more fully set forth below, on as many shares as could be purchased on
the open market for  $100,000 at the closing bid price on  September  24,  2004,
which  option shall be  evidenced  by an option  agreement in the form  attached
hereto as Exhibit B. This  contract  may be  cancelled by either party on ninety
(90) days written notice.

      At the  conclusion  of 12 months,  should this contract not be canceled by
either party on 90 days prior written notice, or modified,  by mutual agreement,
the same terms will pertain to the next 12 month period, except that WSC will be
granted an additional  five-year option on as many shares as could be bought for
$100,000 using as the exercise price,  the closing bid price (or last sale price
if the common  stock shall be listed on a national  securities  exchange) of the
common  stock  on the  anniversary  of the  date of this  Agreement.  Each  year
thereafter,  this additional option grant and formula will be maintained,  until
this agreement shall be canceled or modified, with each such option to be on the
terms and conditions of Exhibit A attached hereto.

      DNAPrint  agrees,  with respect to all options granted under this contract
that for so long as such  options  remain  exercisable  and for a period  of two
years  thereafter,  whenever  DNAPrint  proposes to file with the Securities and
Exchange Commission a registration statement (other than as to securities issued
pursuant to an employee  benefit plan or as to a merger,  acquisition or similar
transaction subject to Rule 145 promulgated under the Securities Act of 1933, as
amended),  DNAPrint shall,  at least 30 days prior to such filing,  give written
notice of the proposed  filing to WSC (or its successor or assigns,  as the case
may be) setting forth the facts with respect to such proposed filing,  and offer
to  include  in any such  filing  all of the  shares  subject  to such  options,
provided that DNAPrint receives a request at least 10 days prior to the proposed
filing date. All fees,  disbursements and  out-of-pocket  expenses in connection
with the filing of any  registration  statement and in complying with applicable
securities  and blue sky laws shall be borne by DNAPrint,  all as more fully set
forth in the option agreement.


                                      -1-
<PAGE>

      This agreement can be canceled by either party on ninety (90) days written
notice.  Should this  agreement be canceled  earlier than one year from the date
hereof as reflected below, WSC will return to DNAPrint a prorated portion of the
five-year  stock  option,  which  portion  shall be based on the  number of days
remaining in the twelve month retainer  period.  For this purpose (and all other
purposes  of this  agreement),  the ninety (90) day period  following  notice of
termination shall be considered part of the retainer period.

      It is  understood  that  during  the 90 day  period  following  notice  of
termination,  DNAPrint  will  continue  to  honor  its fee  arrangement  to WSG,
including  reimbursement of reasonable  expenses,  and that WSG will continue to
work on behalf of DNAPrint.

      In addition to introductions to brokers,  analysts,  money managers, funds
and  institutions,  WSG, will  introduce  DNAPrint to financing  and  investment
banking  sources  that can  potentially  assist in  raising  capital.  If WSG is
successful  in raising  capital  for  DNAPrint  through  sources  which have not
previously  been  introduced  to  DNAPrint  or any of its  officers,  directors,
employees or consultants,  it shall receive a 3.0% success fee of any additional
funds raised.

      Any disputes  arising under or in connection  with the  interpretation  of
this  Agreement  or the rights and  obligations  of the parties  hereto shall be
resolved by  arbitration in the City of New York under the rules of the American
Arbitration Association then obtaining.  The decision of the arbitrator(s) shall
be final and binding,  and judgment may be entered  thereon in the Supreme Court
of the State of New York or in the United States District Court for the Southern
District of New York or any court having  jurisdiction.  The costs and expenses,
including  counsel  fees,  shall  be  borne  by  each of the  parties  or as the
arbitrator(s) may determine at the request of any party.

      As financial public relations  counsel WSG must rely upon the accuracy and
completeness  of the  information  supplied by  DNAPrint  and its  officers  and
directors.   DNAPrint   assumes  full   responsibility   for  the  accuracy  and
completeness of such information. DNAPrint agrees to indemnify WSG and pay WSG's
reasonable costs and expenses  (including,  without limitation,  attorneys' fees
and costs) in any suit or proceeding  arising out of any  materially  inaccurate
information  provided by DNAPrint or any of its officers,  directors,  agents or
employees to WSG. Additionally,  WSG agrees to issue no press releases on behalf
of DNAPrint  which have not been cleared or reviewed by Mr.  Richard  Gabriel or
any other corporate officer he may designate.

      If this  agreement  meets  with your  approval,  please  sign one copy and
return it to me, along with a check  representing  the first month's fee and the
completed Stock Option Agreement while retaining the other copy for your files.

                                  Very truly yours,


                                  Donald Kirsch
                                  President

DK/jg


                                      -2-
<PAGE>

AGREED TO:

DNAPrint genomics, Inc.


By:
   -------------------------------------------
   Richard Gabriel
   President & CEO

Dated:
      ----------------------------------------


                                      -3-